Evo ICL: pioneering the next era of refractive surgery

This presentation explores the challenges posed by the global rise in myopia and the innovative Evo ICL solution, offering a cornea-preserving, FDA-approved technology ideal for patients with thin corneas or dry eyes. We will delve into its advanced features, clinical efficacy with 99.4% patient satisfaction, and its superiority over LASIK. Emphasis will be placed on postoperative care, including lens positioning, long-term biocompatibility, and complication prevention. Lastly, we will...